One pill, four questions: what we still need to know about reducing cardiovascular risk with combination therapy
- PMID: 24818243
- PMCID: PMC4947383
- DOI: 10.1002/14651858.ED000079
One pill, four questions: what we still need to know about reducing cardiovascular risk with combination therapy
Comment on
-
Fixed-dose combination therapy for the prevention of cardiovascular disease.Cochrane Database Syst Rev. 2014 Apr 16;4(4):CD009868. doi: 10.1002/14651858.CD009868.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Mar 06;3:CD009868. doi: 10.1002/14651858.CD009868.pub3. PMID: 24737108 Free PMC article. Updated.
References
-
- Laveran A. Le trypanroth dans le traitement de quelques Trypanosomiases. Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences 1904;139:19–22.
-
- Laing R, Fourie B, Ellard G, Sesay M, Spinaci S, Blomberg B, et al. Fixed‐dose combination tablets for the treatment of tuberculosis: report from an informal meeting held in Geneva. Tuesday, 27 April 1999. Report No.: WHO/CDS/CPC/TB/99.267. whqlibdoc.who.int/hq/1999/WHO_CDS_CPC_TB_99.267.pdf
-
- Sica DA. Rationale for fixed‐dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002;62(3):443–62. doi.org/10.2165/00003495‐200262030‐00003 - PubMed
-
- Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419–25. doi.org/10.1136/bmj.326.7404.1419 - PMC - PubMed
-
- Smith R. The most important BMJ for 50 years? BMJ 2003;326(7404):0.7.doi.org/10.1136/bmj.326.7404.0‐f
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical